• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Universal SARS-CoV-2 testing for obstetric inpatient units across the United States

Mary Wilson

Well-known member
Published: 17 November 2021

https://doi.org/10.1093/cid/ciab955

Jennifer Gilner, MD1; Namita Kansal, MPH1; Joseph R. Biggio, MD2; Shani Delaney, MD3; Chad A. Grotegut, MD4; Erica Hardy, MD5; Adi Hirshberg, MD6; Alisa Kachikis, MD3; Sylvia M. LaCourse, MD3; Jane Martin, MD2,7; Torri D. Metz, MD8; Emily S. Miller, MD9; Mary E. Norton, MD11; Rachel Sinkey, MD10; Nasim C. Sobhani, MD11; Shannon L. Son, MD8; Sindhu Srinivas, MD6; Alan Tita, MD10; Erika F. Werner, MD12; Brenna L. Hughes, MD1

Abstract

Background:
The purpose of this study was to estimate prevalence of asymptomatic SARS-CoV-2 infection among patients admitted to obstetric inpatient units throughout the United States as detected by universal screening. We sought to describe the relationship between obstetric inpatient asymptomatic infection rates and publicly available surrounding community infection rates.

Methods:
This was a cross-sectional study in which medical centers reported rates of positive SARS- CoV-2 testing in asymptomatic pregnant and immediate postpartum patients over a 1–3-month time span in 2020. Publicly reported SARS-CoV-2 case rates from the relevant county and state for each center were collected from the COVID Act Now dashboard and the COVID Tracking Project for correlation analysis.

Results:
Data were collected from nine health centers, encompassing 18 hospitals. Participating health centers were located in Alabama, California, Illinois, Louisiana, New Jersey, North Carolina, Pennsylvania, Rhode Island, Utah, and Washington State. Each hospital had an active policy for universal SARS-CoV-2 testing on obstetric inpatient unit. A total of 10,147 SARS-CoV-2 tests were administered, of which 124 were positive (1.2%). Positivity rates varied by site, ranging from 0-3.2%. While SARS-CoV-2 infection rates were lower in asymptomatic obstetric inpatient groups than the surrounding communities, there was a positive correlation between positivity rates in obstetric inpatient units and their surrounding county (p=.003, r=.782) and state (p=.007, r=.708).

Conclusions:
Given the correlation between community and obstetric inpatient rates, the necessity of SARS-CoV-2 related healthcare resource utilization in obstetric inpatient units may be best- informed by surrounding community infection rates.

https://watermark.silverchair.com/c...KkE8XGTnD9h-H1E8p2BrtolQ5QpjBa58mbzBZ289Hk-kz
 
Back
Top Bottom